Health and Medicine

FSI’s researchers assess health and medicine through the lenses of economics, nutrition and politics. They’re studying and influencing public health policies of local and national governments and the roles that corporations and nongovernmental organizations play in providing health care around the world. Scholars look at how governance affects citizens’ health, how children’s health care access affects the aging process and how to improve children’s health in Guatemala and rural China. They want to know what it will take for people to cook more safely and breathe more easily in developing countries.

FSI professors investigate how lifestyles affect health. What good does gardening do for older Americans? What are the benefits of eating organic food or growing genetically modified rice in China? They study cost-effectiveness by examining programs like those aimed at preventing the spread of tuberculosis in Russian prisons. Policies that impact obesity and undernutrition are examined; as are the public health implications of limiting salt in processed foods and the role of smoking among men who work in Chinese factories. FSI health research looks at sweeping domestic policies like the Affordable Care Act and the role of foreign aid in affecting the price of HIV drugs in Africa.

-

This event is part of the Asia Health Policy Program (AHPP) 2020-21 Colloquium series "Health, medicine, and longevity: Exploring public and private roles"

A quarter century ago in a seminal paper, Hart, Shleifer and Vishny (NBER1996, QJE1997) developed a theory of the ‘Proper Scope of Government.’ In this webinar, Oliver Hart, 2016 Nobel Laureate, reflects on that framework and its place in economics, as well as the inspiration for his more recent work on norms and guiding principles, contracts as reference points, maximizing shareholder welfare, and exit versus voice. In discussion with Karen Eggleston, Hart answers questions posed by economists who have built upon that paper and offers insights on how the theory applies to understanding public and private roles in healthcare, education, and other publicly-financed services. With China, India, and many other emerging markets engaged in decades-long controversies about public and private roles in their health sectors, and international focus on public-private partnerships for COVID-19 response and harnessing innovation to address other global challenges, this is an opportune time to discuss how conceptually rigorous thinking can inform a sometimes divisive and ideological debate with vital implications for human welfare.


Image
Oliver Hart 021021
Oliver Hart is currently the Lewis P. and Linda L. Geyser University Professor at Harvard University, where he has taught since 1993. He is the 2016 co-recipient of the Sveriges Riksbank Prize in Economic Sciences in Memory of Alfred Nobel, a Fellow of the Econometric Society, the American Academy of Arts and Sciences, the British Academy, and the American Finance Association, a member of the National Academy of Sciences, a Distinguished Fellow of the American Economic Association, and has several honorary degrees. Hart works mainly on contract theory, the theory of the firm, corporate finance, and law and economics. His research centers on the roles that ownership structure and contractual arrangements play in the governance and boundaries of corporations. He has published a book (Firms, Contracts, and Financial Structure, Oxford University Press, 1995) and numerous journal articles. He has used his theoretical work on firms and contracts in several legal cases. He has been president of the American Law and Economics Association and a vice president of the American Economic Association.

This keynote is part of the Stanford Asia Health Policy Program colloquium series entitled:  Health, medicine, and longevity: Exploring public and private roles

Governmental agencies and non-state actors interact within health systems in complicated and sometimes controversial ways that are vital for health and well-being. These run the gamut from developing and distributing vaccines and therapeutics for COVID-19 and mitigating the social and economic impact of the pandemic, to achieving and sustaining universal health coverage, addressing the social determinants of health, mitigating disparities, and encouraging innovations for healthy longevity, to name but a few. From the conceptual foundations to the daily reality of practitioners, this colloquium series will explore the evidence and experience of the public-private nexus in health sectors across Asia, in comparative global perspective. With colloquia throughout the academic year, the series features a keynote on February 10, 2021 from Nobel Laureate Oliver Hart, “A quarter century of ‘The Proper Scope of Government’: Theory and Applications” (dating from the 1996 NBER working paper subsequently published in the Quarterly Journal of Economics, QJE).

https://www.youtube.com/watch?v=g9JRhGpXC2Y&feature=emb_title

Via Zoom Webinar.
Register https://bit.ly/3jAvFFQ

Oliver Hart Lewis P. and Linda L. Geyser University Professor, Harvard University
Seminars
-

This event is part of the Asia Health Policy Program (AHPP) 2020-21 Colloquium series "Health, medicine, and longevity: Exploring public and private roles"

Co-sponsored by the Asia Health Policy Program and the Southeast Asia Program

Jakarta time: Friday, October 30, 2020, 7:30am - 9:00am

Apart from the 1998 Asian Financial Crisis (AFC), the current COVID-19 economic crisis is Indonesia’s most serious economic calamity in half a century with adverse impact. In March 2020, Indonesia’s poverty rate increased from 9.41% to 9.78% year on year, the equivalent of 1.28 million new people entering poverty.  By the end of 2020, it is expected that poverty rates will increase above 10%, wiping out two years of Indonesia’s poverty alleviation achievements. Social protection is key for crisis recovery. Indonesia’s social protection system has continually become stronger since the AFC. Over the past two decades, Indonesia has significantly expanded its social protection programs and coverage buttressed by a robust social registry that covers the poorest 40% of the population. The COVID-19 crisis is pushing the system to its limits. Insufficient data on Indonesians vulnerable to falling into poverty (and above the poorest 40%), coupled with response programs with complicated delivery and eligibility mechanisms, has made it challenging to deliver response-focused social protection. Dr. Sumarto will discuss whether the current social protection system is strong enough to weather the storm, especially to protect those working in the informal sector and marginal groups. Today, Indonesian policymakers have the choice to keep on following the same path and continue investing on the same social protection system, or take a radical move to reform it and make it better equipped to face future challenges.

Image
Sudarno Sumarto 102920
Sudarno Sumarto is an economist specializing in poverty reduction, social protection, labor, health, education and political economy of public policy implementation. Before joining the TNP2K, he was previously a visiting scholar at the Shorenstein Asia Pacific Research Center (APARC) at Stanford University as well as Founder and Executive Director of The SMERU Research Institute. Well-versed in leading large-scale research projects, Sudarno also provides intellectual leadership to Indonesia’s RISE country team. His research has been widely published in high-impact journals such as the Journal of Political Economy, Journal of Development Economics, and World Bank Economic Review, and has extensively contributed to policy-making by the Government of Indonesia. Sudarno earned his doctoral and master’s degrees in economics from Vanderbilt University.

 

Via Zoom Webinar.
Register https://bit.ly/30vi2jJ

Sudarno Sumarto Policy Adviser, National Team for the Acceleration of Poverty Reduction (TNP2K), Senior Research Fellow, The SMERU Research Institute.
Seminars
-

This event is part of the Asia Health Policy Program (AHPP) 2020-21 Colloquium series "Health, medicine, and longevity: Exploring public and private roles"

Hong Kong time: Friday, October 16, 2020, 8:00am - 9:15am

Gabriel Leung, one of Asia’s leading epidemiologists and Dean of Medicine at the University of Hong Kong, provides an update on the global pandemic and policy responses in Asia. Leung’s presentation draws on his deep experience in research and policy, including research that defined the epidemiology of three novel viral epidemics, namely SARS in 2003, influenza A(H7N9) in 2013 and most recently COVID-19. Leung also served as Hong Kong's first Under Secretary for Food and Health (2008-11) and fifth Director of the Chief Executive's Office (2011-2).

Image
Gabriel Leung 101520
Gabriel Leung is the fortieth Dean of Medicine (2013-), inaugural Helen and Francis Zimmern Professor in Population Health and holds the Chair of Public Health Medicine at the University of Hong Kong (HKU). He was the last Head of Community Medicine (2012-3) at the University as well as Hong Kong's first Under Secretary for Food and Health (2008-11) and fifth Director of the Chief Executive's Office (2011-2) in government.

Leung is one of Asia's leading epidemiologists and global health exponents, having authored more than 500 scholarly papers with an h-index of 66 (Scopus). His research defined the epidemiology of three novel viral epidemics, namely SARS in 2003, influenza A(H7N9) in 2013 and most recently COVID-19. He led Hong Kong government's efforts against pandemic A(H1N1) in 2009. He was founding co-director of HKU's World Health Organisation (WHO) Collaborating Centre for Infectious Disease Epidemiology and Control (2014-8) and currently directs the Laboratory of Data Discovery for Health at the Hong Kong Science and Technology Park (2020-).

Leung regularly advises national and international agencies including the World Health Organisation, World Bank, Asian Development Bank, Boao Forum for Asia, Institut Pasteur, Japan Center for International Exchange and China Centers for Disease Control and Prevention. He is an Adjunct Professor of Peking Union Medical College Hospital and Adjunct Professorial Researcher of the China National Health Development Research Center.

He edited the Journal of Public Health (2007-14), was inaugural co-editor of Epidemics, associate editor of Health Policy and is founding deputy editor-in-chief of China CDC Weekly. He currently serves on the editorial boards of seven journals, including the British Medical Journal.    

He is an elected member of the US National Academy of Medicine.

Via Zoom Webinar

Register at https://bit.ly/33jLhGO

Gabriel Leung Dean of Medicine, University of Hong Kong
Seminars
Authors
News Type
News
Date
Paragraphs

The world’s population is aging at a faster rate and in larger cohorts than ever before. In countries like Japan that have low fertility rates and high life expectancy, population aging is a risk to social sustainability. Developing policies and healthcare infrastructure to support aging populations is now critical to the social, economic, and developmental wellbeing of all nations. As the COVID-19 pandemic has repeatedly shown, accurate projections of future population health status are crucial for designing sustainable healthcare services and social security systems.

Such projections necessitate models that incorporate the diverse and dynamic associations between health, economic, and social conditions among older people. However, the currently available models – known as multistate transition microsimulation models – require high-quality panel data for calibration and meaningful estimates. Now a group of researchers, including APARC Deputy Director and Asia Health Policy Program Director Karen Eggleston, has developed an alternative method that relaxes this data requirement.

In a newly published paper in Health Economics, Eggleston and her colleagues describe their study that proposes a novel approach using more readily-available data in many countries, thus promising more accurate projections of the future health and functional status of elderly and aging populations. This alternative method uses cross‐sectional representative surveys to estimate multistate‐transition contingency tables applied to Japan's population. When combined with estimated comorbidity prevalence and death record information, this method can determine the transition probabilities of health statuses among aging cohorts.

In comparing the results of their projections against a control, Eggleston and her colleagues show that traditional static models do not always accurately forecast the prevalence of some comorbid conditions such as cancer, heart disease, and stroke. While the sample sets used to test the new methodology originate in Japan, the proposed multistate transition contingency table method has important applications for aging societies worldwide. As rapid population aging becomes a global trend, the ability to produce robust forecasts of population health and functional status to guide policy is a universal need.

Read the full paper in Health Economics.

Learn more about Eggleston’s research projects >>

Read More

A communications robot named Pepper by Softbank
Q&As

Robots May Be the Right Prescription for Struggling Nursing Homes

Karen Eggleston and Yong Suk Lee speak to the Oliver Wyman Forum on how robotics and advancing technologies are helping staff in Japanese nursing homes provide better and safer care to their patients.
Robots May Be the Right Prescription for Struggling Nursing Homes
Portrait of Young Kyung Do, Winner of the 2020 Rothman Epidemiology Prize
News

Asia Health Policy Program Alum Wins Rothman Epidemiology Prize

Dr. Young Kyung Do, an expert in health policy and management at the Seoul National University College of Healthy Policy and the inaugural postdoctoral fellow in Asia health policy at APARC, has been awarded the 2020 prize for his outstanding publication in the journal Epidemiology last year.
Asia Health Policy Program Alum Wins Rothman Epidemiology Prize
Cover image of the book "Healthy Aging in Asia", showing a smiling elderly Chinese woman with a cane standing in a small village.
News

New Book Highlights Policy Initiatives and Economic Research on Healthy Longevity Across Asia

Asia health policy expert Karen Eggleston’s new volume, ‘Healthy Aging in Asia,’ examines how diverse Asian economies – from Singapore and Hong Kong to Japan, India, and China – are preparing for older population age structures and transforming health systems to support patients who will live with chronic disease for decades.
New Book Highlights Policy Initiatives and Economic Research on Healthy Longevity Across Asia
Hero Image
An elderly individual travels in a cart up a street.
An elderly individual travels in a cart up a street.
Galen Crout, Unsplash
All News button
1
Subtitle

Asia Health Policy Director Karen Eggleston and her colleagues unveil a multistate transition microsimulation model that produces rigorous projections of the health and functional status of older people from widely available datasets.

Paragraphs

Effective as of July 1, 2018, South Korea set a new cap on employees’ weekly working hours, decreasing the maximum number from 68 to 52. In this study, we comprehensively analyze the effectiveness of the law’s implementation by observing changes in work time, health status, health care utilization, health behavior, monthly expenses, and satisfaction between pre- and post-implementation periods (2014–2017 vs. 2019). We find evidence of both intended and unintended consequences—and, in this last category, some are beneficial and some not. As intended, employees eligible for the 52-hour work week saw their average working hours decrease, while their monthly spending on leisure increased substantially. A beneficial unintended consequence was that work time also decreased in firms with less than 300 employees that had not yet implemented the 52-hour work schedule (they have done so since, in January 2020). Among adverse unintended consequences, the most notable were heterogeneous effects across employment types (full-time vs. precarious employment) and, in particular, negative impacts on precarious employees (that is, those facing relatively high levels of job insecurity). Despite almost no change in their work time, precarious employees saw substantial increases in outpatient visits and monthly expenses for health care, indicating suggestive evidence of adverse health consequences. Another adverse unintended consequence was that overall job satisfaction decreased among several groups of employees. This may reflect a heavy workload among employees still expected to work overtime, especially experienced employees or those working in large firms. While employment rates increased after the new schedule’s implementation, the majority were in precarious jobs. This has negative implications because of the adverse health impacts of being in precarious employment; also, the workload of experienced employees in this field might have intensified amid all the new hiring. Our findings suggest key policy recommendations for how to leverage the benefits of the 52-hour cap on weekly working hours while addressing its negative unintended consequences.

All Publications button
1
Publication Type
Working Papers
Publication Date
Journal Publisher
Asia Health Policy Program working paper # 59
Authors
Paragraphs

COVID-19 presents humanity with not just a health crisis but also a governance crisis as leaders around the globe confront the challenges of stemming the spread of the virus. Various governments have responded in various ways to slow the transmission of the virus. Ideally, the leaders of a country should approach the crisis with a two-pronged attack. The first is to flatten the epidemic curve (epi curve), which is simply a graphical representation of the number of cases and date of onset of the illness, and the second is to raise or strengthen the capacity of the health system. 

Flattening the epi curve includes mass testing for COVID-19, which has been done in South Korea, for example. Decreasing the incidence also includes quarantine, isolation, and other social distancing strategies, which have been done by various countries in varying degrees. For example, in China, total lockdown (cordon sanitaire) was implemented in Wuhan, of the Hubei province, while in the Philippines, the entire Luzon, which consists of eight administrative regions, including the national capital region (NCR), was in total lockdown (enhanced community quarantine, or ECQ) since March 16 (World Health Organization [WHO] 2020a). Other parts of the Philippines were under different degrees of quarantine at different periods since the appearance of local transmission.

Raising the health care system capacity of a country may include, but is not limited to, training of health care workers, increasing facilities or hospitals that receive COVID patients, and providing adequate personal protective equipment (PPE).

This paper offers a brief epidemiological review of COVID-19 since its first case in China and how the hotspots for this disease evolved and changed over a relatively short period. This paper also aims to provide a short descriptive review of the existing data on COVID-19 in the Association of Southeast Asian Nations (ASEAN) region and the government response of its ten member countries, so that we can somehow draw lessons and learn from these myriad experiences as we continue to combat the spread of this dangerous pathogen. The findings in this paper are preliminary, and more rigorous analysis is expected to be performed as the data becomes more extensive and available.

All Publications button
1
Publication Type
Working Papers
Publication Date
Journal Publisher
Asia Health Policy Program working paper # 58
Authors
Marjorie Pajaron
Authors
News Type
News
Date
Paragraphs

The Walter H. Shorenstein Asia-Pacific Research Center (APARC) condemns the systemic nature and brutal expression of racism in the United States, and we stand in full support of protestors and civil rights organizations in their calls for social justice, equal access to basic rights, and accountability. Beyond reaffirming our commitment to these values, we recognize the imperative to do better as an institution and the urgent need to take concrete action to build a more inclusive community here at our Stanford home. We have joined our colleagues at the Freeman Spogli Institute for International Studies in developing specific steps towards that goal. But we also want to take initial, immediate action in moving from protest to progress.

That’s why we are announcing today a new diversity grant to support Stanford students from underrepresented minorities with an interest in studying issues related to contemporary Asia. The field of Asian studies suffers from an extreme paucity of students, scholars, and experts who self-identify as Black/African American or as affiliated with other underrepresented minority groups. “The path towards a more diverse and inclusive field isn’t easy or straightforward, but we must get on it,” says APARC Director and FSI Senior Fellow Gi-Wook Shin. “We believe that we can tackle the existing disparity if relevant stakeholders across institutes of higher learning all work together. APARC is looking to start this change at Stanford.”

Lowering Barriers to Diversity in Asian Studies

The purpose of the APARC Diversity Grant is to encourage Stanford students from underrepresented minorities (URM) to engage in study and research of topics related to contemporary Asia and U.S.-Asia relations, including economic, health, foreign policy, social, political, and security issues. We follow the University’s definition of the URM category as encompassing “all U.S. citizens and permanent residents who have self-identified as American Indian/Alaska Native, Black/African American, Hispanic/Latino, Native Hawaiian/Other Pacific Islander.” This grant opportunity is open to current Stanford undergraduate and graduate students in the URM category from any major or discipline. “This is just a small step to start lowering disciplinary, cultural, and funding barriers that hinder broader student participation in Asian studies,” notes Shin.

APARC will award a maximum of $10,000 per grant to support a wide range of research expenses such as travel to/from research sites, academic conferences, and workshops (dependent on COVID-19 restrictions); conference registration fees; professional development training programs; purchase of physical and digital books or other required materials; and access to relevant online resources. APARC will review grant applications for projects taking place in winter/spring 2021 on a rolling basis starting on September 1, 2020. Reviews of the second round of applications, for projects taking place in summer/fall 2021, will begin on April 1, 2021.

Examples of research topics, in addition to those that Asia scholars typically study, could include China’s growing activities in Africa; understanding the evolving relations between Asian Americans and African Americans in the United States; and comparative examinations of issues such as the treatment of minorities in Asia and the United States or policies that promote anti-discriminatory practices in schools, the workplace, and other settings in Asian countries and the United States.

Application Guidelines

  • Complete the application form and submit it along with these three (3) attachments:
    • A statement (no more than three pages) describing the proposed research activity or project;
    • A current CV;
    • An itemized budget request explaining research expense needs.
  • Arrange for a letter of recommendation from a faculty to be sent directly to APARC. Please note: the faculty members should email their letters directly to Kristen Lee at kllee@stanford.edu.

We will consider only applications that include all supporting documents.

Read More

Portrait of Young Kyung Do, Winner of the 2020 Rothman Epidemiology Prize
News

Asia Health Policy Program Alum Wins Rothman Epidemiology Prize

Dr. Young Kyung Do, an expert in health policy and management at the Seoul National University College of Healthy Policy and the inaugural postdoctoral fellow in Asia health policy at APARC, has been awarded the 2020 prize for his outstanding publication in the journal Epidemiology last year.
Asia Health Policy Program Alum Wins Rothman Epidemiology Prize
Cover image of the book "Healthy Aging in Asia", showing a smiling elderly Chinese woman with a cane standing in a small village.
News

New Book Highlights Policy Initiatives and Economic Research on Healthy Longevity Across Asia

Asia health policy expert Karen Eggleston’s new volume, ‘Healthy Aging in Asia,’ examines how diverse Asian economies – from Singapore and Hong Kong to Japan, India, and China – are preparing for older population age structures and transforming health systems to support patients who will live with chronic disease for decades.
New Book Highlights Policy Initiatives and Economic Research on Healthy Longevity Across Asia
Hero Image
A look at the front of Encina Hall, Stanford
All News button
1
Subtitle

To encourage Stanford students from underrepresented minorities to engage in study and research of topics related to contemporary Asia, the Shorenstein Asia-Pacific Research Center is offering a new Diversity Grant opportunity. Application reviews begin on September 1, 2020.

News Type
Q&As
Date
Paragraphs

This interview was originally produced by the Oliver Wyman Forum.

Coronavirus has dramatically increased the use of technology as governments, healthcare providers, and businesses tackle the pandemic and its devastation. But even before the crisis, Japan, a country long at the forefront of robot production and usage, had begun to use this technology in many of its nursing homes.

About 60 percent of the country’s nursing facilities now use robots. The proliferation of machines has had a relatively minor impact on turnover or wages of caregivers because of strong demand for care, an aging working population, and government subsidies for robot implementation, according to research by Karen Eggleston, the deputy director of the Shorenstein Asia-Pacific Research Center and director of the Asia Health Policy Program (AHPP), Yong Suk Lee, a center fellow and the deputy director of the Korea Program, and Toshi Iizuka, professor at the University of Tokyo and former visiting scholar with AHPP. Robot-adopting nursing homes, the researchers found, had between eight to 11 percent more staff than those who didn't adopt robots.

Caregiving is a physically demanding task. Staff frequently lift residents in and out of bed, and many suffer from back pain. Many of the robots deployed in Japan either help caregivers perform physical tasks or facilitate movement by the residents themselves.

The research couldn’t be timelier. Nursing homes have taken a heavy toll from the coronavirus. The disease has claimed the lives of more than 28,000 residents and workers of care facilities in the United States – approximately 35 percent of all deaths in the nation as of May 11. By contrast, Japan’s overall death toll stands at a little over 900 in early June.

Professors Eggleston and Lee discussed the implications of their research in a Zoom interview with Partha Bose, a partner at Oliver Wyman and a leader of the Oliver Wyman Forum, as well as Jilian Mincer, managing editor of the Oliver Wyman Forum, and Dan Kleinman, the Forum’s digital editor.

[Like what you're reading? Sign up for our newsletters to get content like this delivered directly to your inbox.]

From a labor economics point of view, Japan has been struggling with staffing in these care facilities. What made it much more acceptable for robots to be used in their situation versus other sectors?

Karen Eggleston: Japan has an extreme demography that it’s dealing with. The demand for long-term care is going up quite a bit while the overall population is declining. Although they're relaxing some immigration, there are issues with that. Some of the policy goals were to support robotics and to understand how it complements or substitutes for specific tasks in long-term care — to bring down back pain among care workers, for example — and to explicitly set a target for percentage of healthcare providers and long-term care clients who say it's acceptable to have a robot involved in their care.

They went into it well aware that robots weren't going to completely push out the workforce, but it's all a question of what type of tasks they can be involved with and how they can get an early read on that and start developing appropriate robots and re-engineering the care processes to meet that surge in demand.

What kinds of tasks are robots being used for in Japan right now?

Yong Suk Lee: There are these wearable transfer-aid robots that can actually help care workers lift persons and move around. There are similar types of robots that are non-wearable. And there are robots that directly assist the elderly in their care: They can use these to move around, and related to that, bathing activities, going to the bathroom, and so on.

The main type of robots are monitoring robots. They’re basically a camera system. They signal to the nurses or caregivers in an aid station if there seems to be abnormal movement so that they can actually go there — especially during the night when there's less staffing to actually go and check how the residents are doing. Those are the highest in terms of rate of adoption. And then there are those cute communication types of robots to help patients with dementia communicate with their families and caregivers.
 
What sort of facilities are using these robots? Do they tend to be urban facilities, or can they be anywhere in the country, like rural areas?

Lee: Based on preliminary results, adoption is higher in urban areas, but it's not significantly different. In China, it could differ drastically because there's a huge urban-rural divide in China of public health systems or public service in general. Robots are capital intensive. In South Korea, there are private homes that are wealthier and those could adopt new technologies earlier, but still, adoption in general is not widespread due to sufficient immigrant labor providing care. There could be an urban-rural divide for sure. Because of government subsidies in Japan, it equalizes distribution across regions.
 
Eggleston: We find more part-time or irregular nurses in urban areas. That may seem counterintuitive, but when you think about it, having that concentration of human capital in urban areas might facilitate that kind of part-time work and so on. There are differences we can see in our data between urban and rural homes, but we don't see large differences in terms of robot adoption and use.

Are there kinds of conditions that robots are better suited for than others?

Lee: In general, most robots are related to mobility issues. The biggest consequences of the elderly staying in homes are pressure ulcers on their skin because of their extended time in bed and low levels of mobility. Robots could provide a major contribution if they help residents move about and reduce pressure ulcers.

Communication robots are helpful for patients with dementia. The adoption of those isn't high compared to monitoring robots, but I think it's becoming more accepted and especially helpful for certain types of patients.
 
Do you think robots will be helpful for medical care?

Eggleston: That's the hope. For example, night monitoring reduces the probability of a severe fall which requires hospitalization and so on. There are contentious issues with nursing homes about physical restraints for patients, which are not allowed. And so, adding robots might deal with some of the outcomes. Both the producers and users of robots are hoping this will have a significant impact on the quality of care. 

As you look at how the coronavirus has affected long-term care facilities, do you wonder what the outcomes might've been had some of these facilities had robots?

Lee: Yes. What our findings indicate is that robots are not replacing workers in Japan. They're allowing firms to adopt more nurses — the skilled type of caregivers, which is an important finding directly related to the quality of care. Allowing critical personnel to actually focus more on patients. If there were certain technologies in place, caregivers could have spent their time more efficiently. I believe that's going to be a discussion going forward in the US and in many other countries that have suffered drastically. 

Eggleston: Particularly the communication and monitoring robots would help to some extent. They can save caregivers from having to go room-to-room and enable communication between people at the facility, and also with their households.

We do know that there's a potential there, and it might affect future adoption in nursing homes in the US and elsewhere. But given the huge financial hit the industry has taken as a whole, it might be a while before that plays out.

Given the coronavirus’s prevalence in nursing homes, people may be wary of taking jobs there. Can these robots be used in a recruiting capacity for nursing homes?

Lee: Certified nursing assistants in the US are not well-paid and it’s a physically demanding job. Now there's an extra concern of, "What will happen to me when I work here?" A lot of nursing homes had enormous difficulty recruiting people. They were paying extra for nurse aids, but they weren't able to recruit given the situation.

Potentially, nursing home facilities that have the capacity to adopt robots may be able to advertise this as not only being able to improve the quality of care for the residents but providing better work conditions for the caregivers. What we're finding in our research is those that adopt these robots tend to have better management practices.

What has surprised you most in your research?

Lee: We didn't find that robots replaced care workers. They’re being used to supplement the workers and maybe have better outcomes in quality of care. This is having an overall net positive effect both on jobs and productivity.

Read More

Cover image of the book "Healthy Aging in Asia", showing a smiling elderly Chinese woman with a cane standing in a small village.
News

New Book Highlights Policy Initiatives and Economic Research on Healthy Longevity Across Asia

Asia health policy expert Karen Eggleston’s new volume, ‘Healthy Aging in Asia,’ examines how diverse Asian economies – from Singapore and Hong Kong to Japan, India, and China – are preparing for older population age structures and transforming health systems to support patients who will live with chronic disease for decades.
New Book Highlights Policy Initiatives and Economic Research on Healthy Longevity Across Asia
Michael McFaul, Xueguang Zhou, Karen Eggleston, Gi-Wook Shin, Don Emmerson, and Yong Suk Lee
News

FSI Hosts APARC Panel on COVID-19 Impacts in Asia

Scholars from each of APARC's programs offer insights on policy responses to COVID-19 throughout Asia.
FSI Hosts APARC Panel on COVID-19 Impacts in Asia
Hero Image
A robot names Pepper Courtesy of Alex Knight, Unsplash
All News button
1
Subtitle

Karen Eggleston and Yong Suk Lee speak to the Oliver Wyman Forum on how robotics and advancing technologies are helping staff in Japanese nursing homes provide better and safer care to their patients.

News Type
News
Date
Paragraphs

On May 15, 2020, the King Center on Global Development held a virtual panel discussion with the Shorenstein APARC on the economic impact of COVID-19 in China. As China lifts its lockdown and U.S. cases of COVID-19 ramp up, three APARC faculty members — Karen Eggleston, Scott Rozelle, and Xueguang Zhou — joined the King Center’s China Program Director Hongbin Li to analyze the Chinese government’s initial response to the coronavirus outbreak and how the virus has impacted urban and rural employment in China’s health care sectors. Watch the panel discussion:

Read More

Michael McFaul, Xueguang Zhou, Karen Eggleston, Gi-Wook Shin, Don Emmerson, and Yong Suk Lee
News

FSI Hosts APARC Panel on COVID-19 Impacts in Asia

Scholars from each of APARC's programs offer insights on policy responses to COVID-19 throughout Asia.
FSI Hosts APARC Panel on COVID-19 Impacts in Asia
Hero Image
Karen Eggleston, Hongbin Li, Scott Rozelle, and Xueguang Zhou during a virtual panel discussion
All News button
1
Subtitle

Karen Eggleston, Scott Rozelle, and Xueguang Zhou join the King Center on Global Development’s Hongbin Li to examine how COVID-19 has impacted urban and rural employment in China’s health care sectors.

Date Label
-

This event is via Zoom Webinar. Please register in advance for the webinar by using the link below.

REGISTRATION LINKhttps://bit.ly/2xZHser

Part of APARC series COVID-19 IN ASIA: RESPONSES AND IMPLICATIONS FOR THE REGION

Co-sponsored by the Asia Health Policy Program and the Southeast Asia Program

Speakers (live and pre-recorded):

Dr. Dorairaj Prabhakaran, Professor of chronic disease epidemiology, Public Health Foundation of India, and Executive Director, Center for Chronic Disease Control.

Dr. Pham Quang Thai, Member of the Vietnam Steering Committee for COVID-19 Prevention and Control

Dr. HAC Van Vinh, Associate Professor & former Dean of Research & International Relations, Thai Nguyen University of Medicine and Pharmacy

Dr. Richard Cash, Senior Lecturer on Global Health, T.H. Chan School of Public Health, Harvard University

Dr. Radhika Jain, Asia Health Policy Postdoctoral Fellow, APARC, FSI, Stanford University

Dr. Arzan Tarapore, Research Scholar, APARC, FSI, Stanford University

How is the pandemic impacting health systems and society in south and southeast Asia? Numerous experts share their perspectives on topics ranging from COVID-19 challenges in Bangladesh, India and Vietnam, to geopolitical considerations for U.S. policy in the wider Indo-Pacific.

Via Zoom Webinar.

Register at https://bit.ly/2xZHser

Dorairaj Prabhakaran Professor of chronic disease epidemiology, Public Health Foundation of India, and Executive Director, Center for Chronic Disease Control.
Pham Quang Thai Member of the Vietnam Steering Committee for COVID-19 Prevention and Control
HAC Van Vinh Associate Professor & former Dean of Research & International Relations, Thai Nguyen University of Medicine and Pharmacy
Richard Cash Senior Lecturer on Global Health, T.H. Chan School of Public Health, Harvard University
Shorenstein APARC Stanford University Encina Hall E301 Stanford, CA 94305-6055
1
Asia Health Policy Postdoctoral Fellow, 2019-2022
radhika_jain.jpg Ph.D.

Radhika Jain was the Asia Health Policy Postdoctoral Fellow for 2019-2022 at the Walter H. Shorenstein Asia-Pacific Research Center (Shorenstein APARC).  Her research focuses on health care markets, the effectiveness of public health policy, and gender disparities in health.

She completed her doctorate in the Department of Global Health at Harvard University in 2019.  Her dissertation examined the extent to which government subsidies for health care under insurance are captured by private hospitals instead of being passed through to patients, and whether accountability measures can help patients claim their entitlements. Dr. Jain's research has been supported by grants from the Weiss Family Fund and the Jameel Poverty Action Lab (JPAL). She has worked on impact evaluations of health programs in India and on the implementation of HIV programs across several countries in sub-Saharan Africa. She also held a doctoral fellowship at the Center for Global Development.

At Shorenstein APARC, Radhika began new work on understanding the factors that contribute to poor female health outcomes and interventions to increase the effectiveness of public health insurance.

Asia Health Policy Postdoctoral Fellow, APARC, FSI, Stanford University
Arzan Tarapore Research Scholar, APARC, FSI, Stanford University
Panel Discussions
Subscribe to Health and Medicine